Literature DB >> 13034471

Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses.

W M HAMMON, L L CORIELL, P F WEHRLE, J STOKES.   

Abstract

Entities:  

Keywords:  POLIOMYELITIS/prevention and control; SERUM GLOBULIN

Mesh:

Substances:

Year:  1953        PMID: 13034471

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  35 in total

1.  The epidemiology of poliomyelitis; a study of an outbreak in Payson, Utah, 1951.

Authors:  P F WEHRLE
Journal:  Calif Med       Date:  1955-04

2.  Viruses of human diseases.

Authors:  C H STUART-HARRIS
Journal:  Br Med J       Date:  1962-06-30

3.  Estimate of molecular equivalents of antibody required for prophylaxis and therapy of poliomyelitis.

Authors:  K M STEVENS
Journal:  J Hyg (Lond)       Date:  1959-06

4.  Observations on natural poliovirus infections in immunized children.

Authors:  H M GELFAND; J P FOX; D R LEBLANC
Journal:  Am J Public Health Nations Health       Date:  1957-04

5.  [Prevention of poliomyelitis; present and future].

Authors:  P LEPINE
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

6.  Control of acute poliomyelitis by immunization.

Authors:  W GUNN
Journal:  Postgrad Med J       Date:  1956-04       Impact factor: 2.401

7.  [Virus diseases in otorhinolaryngology region].

Authors:  R HAAS
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1955-05-02

8.  The severity of poliomyelitis in multiple-case households.

Authors:  C I LEFTWICH; J M CHAPMAN
Journal:  Public Health Rep       Date:  1954-11       Impact factor: 2.792

9.  Immunization against poliomyelitis.

Authors:  T E BOYD
Journal:  Bacteriol Rev       Date:  1953-12

10.  DISTRIBUTION and use of gamma globulin; a statement issued April 20, 1953, by the Division of Medical Sciences of the National Research Council.

Authors: 
Journal:  Public Health Rep       Date:  1953-07       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.